 |
|
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
Hwang Sik Shin, Baek Gyu Jun, Sang-Wook Yi
Clin Mol Hepatol. 2022;28(4):773-789. Published online 2022 Aug 8 DOI: https://doi.org/10.3350/cmh.2021.0383
|
|
Citations to this article as recorded by
 A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
Journal of Hepatology.2025; 82(2): 235. CrossRef Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection
Chen-Hua Liu, Pin-Nan Cheng, Yu-Jen Fang, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin, Sheng-Shun Yang, Yu-Lueng Shih, Cheng-Yuan Peng, Yu-Ping Chang, Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Journal of Hepatology.2025; 82(4): 582. CrossRef AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
Journal of Hepatology.2025; 82(6): 1080. CrossRef Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer
Ji Shi, Xu Zhu, Jun-Bo Yang
World Journal of Hepatology.2025;[Epub] CrossRef A Global Perspective on Metabolically Driven Primary Liver Cancer: Opportunities and Challenges
Joseph C. Ahn
American Journal of Gastroenterology.2025;[Epub] CrossRef Impact of high body mass index on hepatocellular carcinoma risk in chronic liver disease: A population-based prospective cohort study
Moonho Kim, Baek Gyu Jun, Hwang Sik Shin, Jee-Jeon Yi, Sang Gyune Kim, Sang-Wook Yi, Sona Frankova
PLOS ONE.2025; 20(1): e0316175. CrossRef Hepatocellular carcinoma surveillance after sustained virological response in chronic hepatitis C: Editorial on “Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-ana
Ho Soo Chun, Minjong Lee
Clinical and Molecular Hepatology.2025; 31(1): 261. CrossRef Exploring How Adipose Tissue, Obesity, and Gender Influence the Immune Response to Vaccines: A Comprehensive Narrative Review
Juan Bautista De Sanctis, Germán Balda Noria, Alexis Hipólito García
International Journal of Molecular Sciences.2025; 26(2): 862. CrossRef Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic
Hiroyuki Suzuki, Naoto Fujiwara, Amit G. Singal, Thomas F. Baumert, Raymond T. Chung, Takumi Kawaguchi, Yujin Hoshida
Hepatology.2025;[Epub] CrossRef Statins exposure and adverse events in participants with chronic viral hepatitis: a meta-analysis based on cohort studies
Jiale Ruan, Yingying Fang, Xingfen Zhang, Qiufeng Zhang, Jian Song
npj Gut and Liver.2025;[Epub] CrossRef Hepatitis C virus-related liver cancer among Medicaid recipients with schizophrenia, 2002–2012
Marilyn D. Thomas, Mandana Khalili, Eric Vittinghoff, Francine Cournos, Mark Olfson, Priya Dahiya, Stephen Crystal, Richard Hermida, Christina Mangurian
Journal of Medicine, Surgery, and Public Health.2025; 6: 100199. CrossRef Modulation of glucose metabolism and insulin resistance following hepatitis C virus clearance via direct-acting antivirals
Sajida Jabeen, Ramsha Khan, May M. Alrashed, Sajjad Ullah, Ghulam Nabi, Malik Ihsan Ullah, Ahmed Bilal Waqar, Kotb A. Attia, Itoh Kimiko
Scientific Reports.2025;[Epub] CrossRef Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms
Ya. V. Dvoryanchikov, S. M. Deunezhewa, I. A. Yatskov, V. A. Beloglazov
Problems of Endocrinology.2025; 71(2): 75. CrossRef The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021
Jinli Liu, Tingling Xu, Yanan Wang, Fanpu Ji, Lei Zhang
Global Health Research and Policy.2025;[Epub] CrossRef Towards elimination of chronic viral hepatitis in French Polynesia: results from a national population-based survey
Iotefa Teiti, Maite Aubry, Philippe Glaziou, Vincent Mendiboure, Anita Teissier, Tuterarii Paoaafaite, Aurélie Simon, Kiyojiken Chung, Lisa Dian, Sophie Olivier, Pascal Pineau, Arnaud Fontanet, Bertrand Condat, Yoann Madec, Stéphane Lastère, Van-Mai Cao-L
The Lancet Regional Health - Western Pacific.2024; 45: 101035. CrossRef Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma
Pinggui Chen, Yaoxuan Li, Yunyan Dai, Zhiming Wang, Yunpeng Zhou, Yi Wang, Gaopeng Li
Journal of Hepatocellular Carcinoma.2024; Volume 11: 581. CrossRef The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco
Cancers.2024; 16(8): 1505. CrossRef Current perspectives of viral hepatitis
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou,
World Journal of Gastroenterology.2024; 30(18): 2402. CrossRef Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin
Marica Meroni, Miriam Longo, Paola Dongiovanni
Frontiers in Endocrinology.2024;[Epub] CrossRef Effectiveness of the ALT/AST ratio for predicting insulin resistance in a Korean population: A large-scale, cross-sectional cohort study
Seul Ki Han, Myung Jae Seo, Taesic Lee, Moon Young Kim, Anna Di Sessa
PLOS ONE.2024; 19(5): e0303333. CrossRef Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
Eugene Han, Yong-ho Lee, Sang Hoon Ahn, Bong-Soo Cha, Seung Up Kim, Byung-Wan Lee
Gut and Liver.2024; 18(3): 509. CrossRef Ensemble learning enhances the precision of preliminary detection of primary hepatocellular carcinoma based on serological and demographic indices
Mengxia Wang, Bo Zhuang, Shian Yu, Gang Li
Frontiers in Oncology.2024;[Epub] CrossRef Air Pollution in Cardio-Oncology and Unraveling the Environmental Nexus
Wenqiang Zhu, Sadeer G. Al-Kindi, Sanjay Rajagopalan, Xiaoquan Rao
JACC: CardioOncology.2024; 6(3): 347. CrossRef Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B
Hyunjae Shin, Gyung Sun Lim, Jae Woong Yoon, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yuri Cho, Yun Bin Lee, Eun Ju Cho, Bo Hyun Kim, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Yoon Jun Kim
Journal of Medical Virology.2024;[Epub] CrossRef Metabolic dysfunction-associated steatotic liver disease and diabetes: the cross-talk between hepatologist and diabetologist
Ming-Lun Yeh, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Ming-Lung Yu, Wan-Long Chuang
Expert Review of Gastroenterology & Hepatology.2024; 18(8): 431. CrossRef Association between obesity and liver cancer from 2012 to 2023: Bibliometric analysis and global trends
Donghong Wang, Zhibin Ma
Medicine.2024; 103(31): e39167. CrossRef Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver‐related mortality in patients with diabetes
Xianhua Mao, Ka‐Shing Cheung, Jing‐Tong Tan, Lung‐Yi Mak, Chi‐Ho Lee, Chi‐Leung Chiang, Ho‐Ming Cheng, Rex Wan‐Hin Hui, Wai K. Leung, Man‐Fung Yuen, Wai‐Kay Seto
Alimentary Pharmacology & Therapeutics.2024; 60(10): 1398. CrossRef Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study
Hiroji Shinkawa, Masaki Kaibori, Masaki Ueno, Satoshi Yasuda, Hisashi Ikoma, Tsukasa Aihara, Takuya Nakai, Masahiko Kinoshita, Hisashi Kosaka, Shinya Hayami, Yasuko Matsuo, Ryo Morimura, Takayoshi Nakajima, Chihoko Nobori, Takeaki Ishizawa
Liver Cancer.2024; : 1. CrossRef Liver Cancer Etiology: Old Issues and New Perspectives
Jian-Guo Chen, Yong-Hui Zhang, Jian-Hua Lu, Thomas W. Kensler
Current Oncology Reports.2024; 26(11): 1452. CrossRef Deep learning assisted biomarker development in patients with chronic hepatitis B: Editorial on “Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection”
Yong Eun Chung
Clinical and Molecular Hepatology.2024; 30(4): 669. CrossRef Clinical care guidance in patients with diabetes and metabolic dysfunction–associated steatotic liver disease: A joint consensus
Jee-Fu Huang, Tien-Jyun Chang, Ming-Lun Yeh, Feng-Chih Shen, Chi-Ming Tai, Jung-Fu Chen, Yi-Hsiang Huang, Chih-Yao Hsu, Pin-Nan Cheng, Ching-Ling Lin, Chao-Hung Hung, Ching-Chu Chen, Mei-Hsuan Lee, Chun-Chuan Lee, Chih-Wen Lin, Sung-Chen Liu, Hwai-I Yang,
Hepatology Communications.2024;[Epub] CrossRef Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma
Natchaya Polpichai, Sakditad Saowapa, Pojsakorn Danpanichkul, Shu-Yen Chan, Leandro Sierra, Johanna Blagoie, Chitchai Rattananukrom, Pimsiri Sripongpun, Apichat Kaewdech
Journal of Clinical Medicine.2024; 13(22): 6770. CrossRef A predicted epithelial-to-mesenchymal transition-associated mRNA/miRNA axis contributes to the progression of diabetic liver disease
Alina-Veronica Ghionescu, Andrei Sorop, Ekaterini Linioudaki, Cristin Coman, Lorand Savu, Marton Fogarasi, Daniela Lixandru, Simona Olimpia Dima
Scientific Reports.2024;[Epub] CrossRef Evolution of characteristics of MASLD with and without diabetes: a meta-analysis of placebo arms
Han Ah Lee, Hye Ah Lee, Hwi Young Kim
Scientific Reports.2024;[Epub] CrossRef Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
Man-Yu Li, Ting-Ting Li, Ke-Jian Li, Cheng Zhou
World Journal of Clinical Cases.2023; 11(5): 1009. CrossRef Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S43. CrossRef Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
Yi-wen Shi, Jian-Gao Fan
Clinical and Molecular Hepatology.2023; 29(Suppl): S228. CrossRef A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
Hao-dan Mao, Shu-qin Zheng, Su-hua Yang, Ze-yu Huang, Yuan Xue, Min Zhou
PeerJ.2023; 11: e15014. CrossRef Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation
Carlo Bosi, Margherita Rimini, andrea Casadei-Gardini, Giorgio Ercolani
Expert Review of Anticancer Therapy.2023; 23(5): 503. CrossRef Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
Mona Mohamed Ibrahim Abdalla
World Journal of Gastroenterology.2023; 29(27): 4271. CrossRef On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B
Zeyuan Yang, Ramsey C. Cheung, Amit S. Chitnis, Wei Zhang, Robert G. Gish, Robert J. Wong
JHEP Reports.2023; 5(10): 100852. CrossRef Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study
Fahim Ebrahimi, Hannes Hagström, Jiangwei Sun, David Bergman, Ying Shang, Wen Yang, Bjorn Roelstraete, Jonas F. Ludvigsson
Journal of Hepatology.2023; 79(6): 1374. CrossRef Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study
Hashem B. El-Serag, Ghida Akhdar, Aaron P. Thrift, Michelle Luster, Saira Khaderi, Abeer Alsarraj, Hao Duong, Fasiha Kanwal
Hepatology Communications.2023;[Epub] CrossRef Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy—Author's reply
Eiichi Ogawa
Alimentary Pharmacology & Therapeutics.2023; 58(8): 845. CrossRef Effects of visceral obesity on cytokine and hormonal regulation in patients with gastroesophageal reflux disease
Yu.M. Stepanov, L.M. Mosiychuk, O.M. Tatarchuk, O.M. Shevtsova, O.P. Petishko
GASTROENTEROLOGY.2023; 57(3): 135. CrossRef Life-long consumption of high level of fruits and vegetables reduces tumor incidence and extends median lifespan in mice
Weimin Guo, Edwin F. Ortega, Dayong Wu, Lijun Li, Roderick T. Bronson, Sarah K. Boehm, Simin Nikbin Meydani
Frontiers in Nutrition.2023;[Epub] CrossRef
|